These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27432187)

  • 1. A novel 33-Gene targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias.
    Roy NB; Wilson EA; Henderson S; Wray K; Babbs C; Okoli S; Atoyebi W; Mixon A; Cahill MR; Carey P; Cullis J; Curtin J; Dreau H; Ferguson DJ; Gibson B; Hall G; Mason J; Morgan M; Proven M; Qureshi A; Sanchez Garcia J; Sirachainan N; Teo J; Tedgård U; Higgs D; Roberts D; Roberts I; Schuh A
    Br J Haematol; 2016 Oct; 175(2):318-330. PubMed ID: 27432187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias.
    Shefer Averbuch N; Steinberg-Shemer O; Dgany O; Krasnov T; Noy-Lotan S; Yacobovich J; Kuperman AA; Kattamis A; Ben Barak A; Roth-Jelinek B; Chubar E; Shabad E; Dufort G; Ellis M; Wolach O; Pazgal I; Abu Quider A; Miskin H; Tamary H
    Eur J Haematol; 2018 Sep; 101(3):297-304. PubMed ID: 29786897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation of targeted next-generation sequencing for inherited disorders.
    Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
    Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases.
    Al-Mousa H; Abouelhoda M; Monies DM; Al-Tassan N; Al-Ghonaium A; Al-Saud B; Al-Dhekri H; Arnaout R; Al-Muhsen S; Ades N; Elshorbagi S; Al Gazlan S; Sheikh F; Dasouki M; El-Baik L; Elamin T; Jaber A; Kheir O; El-Kalioby M; Subhani S; Al Idrissi E; Al-Zahrani M; Alhelale M; Alnader N; Al-Otaibi A; Kattan R; Al Abdelrahman K; Al Breacan MM; Bin Humaid FS; Wakil SM; Alzayer F; Al-Dusery H; Faquih T; Al-Hissi S; Meyer BF; Hawwari A
    J Allergy Clin Immunol; 2016 Jun; 137(6):1780-1787. PubMed ID: 26915675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel.
    Mori T; Hosomichi K; Chiga M; Mandai S; Nakaoka H; Sohara E; Okado T; Rai T; Sasaki S; Inoue I; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):63-75. PubMed ID: 26920127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
    Soukupova J; Zemankova P; Lhotova K; Janatova M; Borecka M; Stolarova L; Lhota F; Foretova L; Machackova E; Stranecky V; Tavandzis S; Kleiblova P; Vocka M; Hartmannova H; Hodanova K; Kmoch S; Kleibl Z
    PLoS One; 2018; 13(4):e0195761. PubMed ID: 29649263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.
    Kedar PS; Harigae H; Ito E; Muramatsu H; Kojima S; Okuno Y; Fujiwara T; Dongerdiye R; Warang PP; Madkaikar MR
    Int J Hematol; 2019 Nov; 110(5):618-626. PubMed ID: 31401766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of an expanded targeted sequencing panel for non-invasive prenatal diagnosis of sporadic skeletal dysplasia.
    Wang CY; Tang YA; Lee IW; Chang FM; Chien CW; Pan HA; Sun HS
    BMC Med Genomics; 2021 Nov; 14(Suppl 3):212. PubMed ID: 34789231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.
    Bastida JM; Del Rey M; Lozano ML; Sarasquete ME; Benito R; Fontecha ME; Fisac R; García-Frade LJ; Aguilar C; Martínez MP; Pardal E; Aguilera C; Pérez B; Ramos R; Cardesa MR; Martin-Antorán JM; Silvestre LA; Cebeira MJ; Bermejo N; Riesco S; Mendoza MC; García-Sanz R; González-Díaz M; Hernández-Rivas JM; González-Porras JR
    Haemophilia; 2016 Jul; 22(4):590-7. PubMed ID: 26879396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive mutation analysis for congenital muscular dystrophy: a clinical PCR-based enrichment and next-generation sequencing panel.
    Valencia CA; Ankala A; Rhodenizer D; Bhide S; Littlejohn MR; Keong LM; Rutkowski A; Sparks S; Bonnemann C; Hegde M
    PLoS One; 2013; 8(1):e53083. PubMed ID: 23326386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
    Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
    Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation sequencing using phenotype-based panels for genetic testing in inherited retinal diseases.
    Shah M; Shanks M; Packham E; Williams J; Haysmoore J; MacLaren RE; Németh AH; Clouston P; Downes SM
    Ophthalmic Genet; 2020 Aug; 41(4):331-337. PubMed ID: 32543920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing for disorders of low and high bone mineral density.
    Sule G; Campeau PM; Zhang VW; Nagamani SC; Dawson BC; Grover M; Bacino CA; Sutton VR; Brunetti-Pierri N; Lu JT; Lemire E; Gibbs RA; Cohn DH; Cui H; Wong LJ; Lee BH
    Osteoporos Int; 2013 Aug; 24(8):2253-9. PubMed ID: 23443412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of Noonan syndrome and related disorders using target next generation sequencing.
    Lepri FR; Scavelli R; Digilio MC; Gnazzo M; Grotta S; Dentici ML; Pisaneschi E; Sirleto P; Capolino R; Baban A; Russo S; Franchin T; Angioni A; Dallapiccola B
    BMC Med Genet; 2014 Jan; 15():14. PubMed ID: 24451042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias.
    Russo R; Andolfo I; Manna F; Gambale A; Marra R; Rosato BE; Caforio P; Pinto V; Pignataro P; Radhakrishnan K; Unal S; Tomaiuolo G; Forni GL; Iolascon A
    Am J Hematol; 2018 May; 93(5):672-682. PubMed ID: 29396846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders.
    Kitamura Y; Kondo E; Urano M; Aoki R; Saito K
    J Hum Genet; 2016 Nov; 61(11):931-942. PubMed ID: 27357428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing.
    Liu Y; Asan ; Ma D; Lv F; Xu X; Wang J; Xia W; Jiang Y; Wang O; Xing X; Yu W; Wang J; Sun J; Song L; Zhu Y; Yang H; Wang J; Li M
    Osteoporos Int; 2017 Oct; 28(10):2985-2995. PubMed ID: 28725987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mirTrios: an integrated pipeline for detection of de novo and rare inherited mutations from trios-based next-generation sequencing.
    Li J; Jiang Y; Wang T; Chen H; Xie Q; Shao Q; Ran X; Xia K; Sun ZS; Wu J
    J Med Genet; 2015 Apr; 52(4):275-81. PubMed ID: 25596308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.